Name of Study

PRIORITY: Pregnancy CoRonavIrus Outcomes RegIsTrY

Principal Investigators

Vanessa Jacoby, MD, MAS 

Co-Principal Investigator​
University of California, San Francisco

Stephanie Gaw, MD, PhD

Co-Principal Investigator
University of California, San Francisco 

Yalda Afshar, MD, PhD

Co-Principal Investigator
University of California, Los Angeles

Valerie Flaherman, MD

Co-Investigator
University of California, San Francisco

Sponsoring Institution

University of California, San Francisco (UCSF) and University of California, Los Angeles (UCLA)

Why is This Study Important?

• What we know
  • There have been case reports describing the experience of pregnant women and infants diagnosed with COVID-19 infection
  • Risk for vertical transmission has not been established but at present there are no clearly documented cases
• What we don’t know
  • Evidence is based on a relatively small number of cases, mostly originating out the U.S.
  • Data remains sparse regarding not only signs and symptoms, but also fetal and newborn risks

Goal of the PRIORITY Study

• To better understand how pregnant women are affected by COVID-19 including
  • Characterize the symptoms
  • Ascertain how long to symptoms last
  • Determine how COVID-19 may impact their pregnancy and/or delivery
• By participating in a registry, data sets can be used to better understand and manage pregnant women during this pandemic

Study Type

National Registry

Methods

• Eligibility
  • Currently pregnant or has been pregnant in the last six weeks
  • Suspected or under investigation for COVID-19 or have a confirmed COVID-19 diagnosis
• IRB
  • UCSF IRB has given permission for physicians to refer a patient and send her contact information as long as she has agreed to send her contact information to us
• Patient Permission and Documentation
  • If the physician would like, she may document in the medical record that the patient has given permission to share her information
  • A template form can be used for this purpose
  • UCSF will ask the patient to sign an authorization to release medical records | The study team will contact the physician’s office to assist us in obtaining medical record information

Enrollment, Consent and Follow-Up

• Enrollment
  • The Study team will reach out to the patient to enroll her in to the study
• Consent
  • Via phone or online
• Follow-up
  • Enrolled while pregnant
    • Once a week for 4 weeks, once a trimester, and then 6 weeks post partum to assess her health outcomes 
  • Enrolled post partum
    • Once a week for 4 weeks, and then 8 weeks post partum to assess her health outcomes

Data Sharing

• Analysis will be quickly conducted
• Findings will be posted on the study website as they become available

How to Refer a Patient

• Email: prioritycovid19@ucsf.edu
• Call: 415-754-3749
• Tap/Click button below

Any Other Way I Can Help the Registry?

Yes! You can donate to PRIORITY at UCSF

For Additional Information

• Email: prioritycovid19@ucsf.edu
• Study Website: https://priority.ucsf.edu/